Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors

Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance the tissue insult, innate immunity is always at the forefront. Cells of innate immunity efficiently recognize the ‘danger signals’ via a speci...

Full description

Saved in:
Bibliographic Details
Published inScandinavian journal of immunology Vol. 95; no. 2; pp. e13124 - n/a
Main Authors Kinra, Manas, Nampoothiri, Madhavan, Arora, Devinder, Mudgal, Jayesh
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance the tissue insult, innate immunity is always at the forefront. Cells of innate immunity efficiently recognize the ‘danger signals’ via a specialized set of membrane‐bound receptors known as Toll‐like receptors. Once this interaction is established, toll‐like receptor passes on the responsibility to cytosolic NOD‐like receptors through a cascade of signalling pathways. Subsequently, NOD‐like receptors assemble to a specialized multiprotein intracellular complex, that is inflammasome. Inflammasome activates Caspase‐1 and Gasdermin‐D which initiate pyroptotic cell death in the affected tissue by two simultaneous mechanisms. Being a protease, caspase‐1 cleaves and activates pro‐inflammatory cytokines IL‐1β and IL‐18. On the other hand, Gasdermin‐D causes proteolytic cleavage which forms a pore in the cell membrane. This review highlights the molecular events ranging from recognition of stimuli to pyroptosis. The review is also an attempt to discuss the mechanisms of the most specific experimental NLRP3 inhibitors.
AbstractList Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance the tissue insult, innate immunity is always at the forefront. Cells of innate immunity efficiently recognize the 'danger signals' via a specialized set of membrane-bound receptors known as Toll-like receptors. Once this interaction is established, toll-like receptor passes on the responsibility to cytosolic NOD-like receptors through a cascade of signalling pathways. Subsequently, NOD-like receptors assemble to a specialized multiprotein intracellular complex, that is inflammasome. Inflammasome activates Caspase-1 and Gasdermin-D which initiate pyroptotic cell death in the affected tissue by two simultaneous mechanisms. Being a protease, caspase-1 cleaves and activates pro-inflammatory cytokines IL-1β and IL-18. On the other hand, Gasdermin-D causes proteolytic cleavage which forms a pore in the cell membrane. This review highlights the molecular events ranging from recognition of stimuli to pyroptosis. The review is also an attempt to discuss the mechanisms of the most specific experimental NLRP3 inhibitors.Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance the tissue insult, innate immunity is always at the forefront. Cells of innate immunity efficiently recognize the 'danger signals' via a specialized set of membrane-bound receptors known as Toll-like receptors. Once this interaction is established, toll-like receptor passes on the responsibility to cytosolic NOD-like receptors through a cascade of signalling pathways. Subsequently, NOD-like receptors assemble to a specialized multiprotein intracellular complex, that is inflammasome. Inflammasome activates Caspase-1 and Gasdermin-D which initiate pyroptotic cell death in the affected tissue by two simultaneous mechanisms. Being a protease, caspase-1 cleaves and activates pro-inflammatory cytokines IL-1β and IL-18. On the other hand, Gasdermin-D causes proteolytic cleavage which forms a pore in the cell membrane. This review highlights the molecular events ranging from recognition of stimuli to pyroptosis. The review is also an attempt to discuss the mechanisms of the most specific experimental NLRP3 inhibitors.
Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance the tissue insult, innate immunity is always at the forefront. Cells of innate immunity efficiently recognize the ‘danger signals’ via a specialized set of membrane‐bound receptors known as Toll‐like receptors. Once this interaction is established, toll‐like receptor passes on the responsibility to cytosolic NOD‐like receptors through a cascade of signalling pathways. Subsequently, NOD‐like receptors assemble to a specialized multiprotein intracellular complex, that is inflammasome. Inflammasome activates Caspase‐1 and Gasdermin‐D which initiate pyroptotic cell death in the affected tissue by two simultaneous mechanisms. Being a protease, caspase‐1 cleaves and activates pro‐inflammatory cytokines IL‐1β and IL‐18. On the other hand, Gasdermin‐D causes proteolytic cleavage which forms a pore in the cell membrane. This review highlights the molecular events ranging from recognition of stimuli to pyroptosis. The review is also an attempt to discuss the mechanisms of the most specific experimental NLRP3 inhibitors.
Author Kinra, Manas
Nampoothiri, Madhavan
Mudgal, Jayesh
Arora, Devinder
Author_xml – sequence: 1
  givenname: Manas
  surname: Kinra
  fullname: Kinra, Manas
  organization: Manipal Academy of Higher Education
– sequence: 2
  givenname: Madhavan
  surname: Nampoothiri
  fullname: Nampoothiri, Madhavan
  organization: Manipal Academy of Higher Education
– sequence: 3
  givenname: Devinder
  surname: Arora
  fullname: Arora, Devinder
  organization: Griffith University
– sequence: 4
  givenname: Jayesh
  orcidid: 0000-0001-8190-7031
  surname: Mudgal
  fullname: Mudgal, Jayesh
  email: jayesh.mudgal@manipal.edu
  organization: Manipal Academy of Higher Education
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34861056$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1uEzEUhS1URNPAghdAltjQxbT-nZ8lqmhpFQEKZT3yzFwTR2N7sJ2m2fEIPCNPUrcpLCrB3dzNd47uPecIHTjvAKHXlJzQPKdxbU4op0w8QzPKS1lwUvMDNCOckKIRlTxERzGuCaGcVfwFOuSiLimR5QzdLuHGwNa47zitABs7-ZCU6wF7ja8Xy98_f31aLL_wvKdd8FPy0UQ8qbTaqh1WbsAW-pVyJtp7BdxOEIwFl9SIH4TYOD0qa1X0Nvu7lelM8iG-RM-1GiO8etxz9O38w_XZx2Lx-eLy7P2i6IUUoqhqoRWjSgrVlV3FlaQgGW204B0ZBBsqPSjasL4nVdNQQnQHjZaC1zXXFRn4HL3b-07B_9hATK01sYdxVA78JrasJGXDJCUso2-foGu_CS5flylGBBdlznWO3jxSm87C0E75XxV27Z9MM3C8B_rgYwyg_yKUtPd9tbmv9qGvzJ4-YXuTVDLepaDM-D_F1oyw-7d1-_Xqcq-4A-5up-A
CitedBy_id crossref_primary_10_1016_j_tcm_2022_05_001
crossref_primary_10_1016_j_phymed_2024_155859
crossref_primary_10_3389_fimmu_2023_1279264
crossref_primary_10_1016_j_jep_2024_118962
crossref_primary_10_1016_j_biopha_2023_115493
crossref_primary_10_1016_j_ygeno_2025_111033
crossref_primary_10_3390_ph16101455
crossref_primary_10_3390_ph17030402
crossref_primary_10_1007_s10753_024_02025_2
crossref_primary_10_1007_s00415_022_11491_3
crossref_primary_10_1016_j_tice_2023_102069
crossref_primary_10_1007_s12035_025_04779_8
crossref_primary_10_1038_s41401_023_01054_1
crossref_primary_10_3389_fphys_2024_1326392
crossref_primary_10_1007_s12035_023_03844_4
crossref_primary_10_1186_s40001_023_01564_y
crossref_primary_10_1016_j_jri_2023_103992
crossref_primary_10_3390_cells11244111
crossref_primary_10_1016_j_ijbiomac_2024_129669
crossref_primary_10_1002_advs_202300824
crossref_primary_10_1007_s12015_023_10520_6
crossref_primary_10_1016_j_biopha_2024_116673
crossref_primary_10_3390_cells11203269
crossref_primary_10_1016_j_bioorg_2023_106362
crossref_primary_10_1007_s12035_023_03437_1
crossref_primary_10_1021_acsnano_3c01760
crossref_primary_10_3390_antiox11020269
crossref_primary_10_1038_s41467_024_46322_8
crossref_primary_10_1002_mco2_311
crossref_primary_10_1002_adtp_202400197
Cites_doi 10.1038/nature09663
10.4049/jimmunol.1101284
10.1111/j.1600-065X.2012.01146.x
10.1038/cmi.2016.29
10.1074/jbc.M113.515080
10.1146/annurev.biochem.71.110601.135414
10.1097/FJC.0000000000000053
10.1038/nri3446
10.1111/febs.12283
10.1016/j.cell.2010.01.040
10.3389/fimmu.2019.02538
10.1186/s12974-019-1471-y
10.1189/jlb.3HI0814-371RR
10.1038/nm.3804
10.1016/j.cyto.2008.01.006
10.3389/fimmu.2014.00316
10.1016/j.immuni.2016.01.012
10.3390/molecules25235533
10.1038/nature11588
10.1002/eji.201545655
10.1111/j.1365-2567.2004.01976.x
10.4110/in.2018.18.e27
10.1152/advan.00058.2013
10.1038/nri2569
10.1146/annurev.biochem.74.082803.133347
10.1038/ni1253
10.1038/nature11729
10.1016/j.bcp.2013.03.008
10.1371/journal.ppat.1000559
10.1104/pp.110.161547
10.1016/j.bbabio.2009.06.004
10.1038/nm.3806
10.1074/jbc.M109.082305
10.1146/annurev.immunol.24.021605.090552
10.1042/BJ20121651
10.1038/nm.3893
10.1152/physrev.00009.2014
10.1007/s00251-020-01158-6
10.1074/jbc.RA118.003314
10.1038/ni.3333
10.1111/j.1365-2141.2009.07988.x
10.1126/science.1102218
10.1038/ni.2215
10.1038/nri2873
10.4049/jimmunol.0901363
10.1016/j.molcel.2012.11.009
10.1016/j.ejps.2020.105637
10.1084/jem.21213insight1
10.1083/jcb.200903124
10.1016/S1097-2765(00)80032-5
10.1074/jbc.R700009200
10.1093/intimm/dxp017
10.1186/s41232-018-0085-6
10.1016/j.immuni.2011.02.006
10.1038/nature16959
10.1007/s00702-017-1686-y
10.1016/j.autrev.2018.01.020
10.1074/jbc.C115.700492
10.1128/CMR.00046-08
10.1074/jbc.M112.381228
10.3109/08830185.2010.529976
10.1128/ecosalplus.ESP-0001-2018
10.1165/rcmb.2006-0323OC
10.1038/s41589-019-0277-7
10.3389/fimmu.2017.00036
10.1016/S1097-2765(02)00599-3
10.4049/jimmunol.179.6.4083
10.1016/j.mam.2020.100924
10.1074/jbc.M109.023044
10.1084/jem.20132486
10.3389/fphar.2015.00262
10.1189/jlb.0306164
10.1126/science.1087262
10.1007/978-3-7643-8550-7_35
10.1038/nrmicro2070
10.1371/journal.ppat.1005596
10.1016/B978-0-12-805417-8.00014-7
10.1097/FJC.0000000000000247
10.1038/nature15514
10.1038/cr.2010.135
10.1073/pnas.0611496104
10.1038/ni.2550
10.1165/rcmb.2011-0135OC
10.1006/bbrc.1997.7672
10.4049/jimmunol.1201644
10.3389/fimmu.2017.01518
10.1038/emm.2013.97
10.2131/jts.41.273
10.1152/ajpcell.00217.2006
10.1016/j.cell.2014.11.047
10.1084/jem.20171419
ContentType Journal Article
Copyright 2021 The Scandinavian Foundation for Immunology.
Copyright © 2022 The Scandinavian Foundation for Immunology
Copyright_xml – notice: 2021 The Scandinavian Foundation for Immunology.
– notice: Copyright © 2022 The Scandinavian Foundation for Immunology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7U9
8FD
FR3
H94
K9.
M7N
NAPCQ
P64
7X8
DOI 10.1111/sji.13124
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Technology Research Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Nursing & Allied Health Premium

MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1365-3083
EndPage n/a
ExternalDocumentID 34861056
10_1111_sji_13124
SJI13124
Genre reviewArticle
Journal Article
Review
GrantInformation_xml – fundername: Griffith University
  funderid: RG/0618111
– fundername: Council for Scientific and Industrial Research
  funderid: 08/602(0005)/19EMR‐I
– fundername: Griffith University
  grantid: RG/0618111
– fundername: Council for Scientific and Industrial Research
  grantid: 08/602(0005)/19EMR-I
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
123
1OB
1OC
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOETA
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IH2
IHE
IPNFZ
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OBS
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
Y6R
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7U9
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
FR3
H94
K9.
M7N
NAPCQ
P64
7X8
ID FETCH-LOGICAL-c4544-784fa21a54ab6b73a51e5219f43b0d42d7fda192cc0799100fbe9f543883f70d3
IEDL.DBID DR2
ISSN 0300-9475
1365-3083
IngestDate Fri Jul 11 11:19:44 EDT 2025
Fri Jul 25 10:10:47 EDT 2025
Wed Feb 19 02:27:09 EST 2025
Tue Jul 01 03:57:01 EDT 2025
Thu Apr 24 22:51:35 EDT 2025
Wed Jan 22 16:27:40 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords NLRP3 inflammasome
Pyroptosis
inflammasome inhibitors
Language English
License 2021 The Scandinavian Foundation for Immunology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4544-784fa21a54ab6b73a51e5219f43b0d42d7fda192cc0799100fbe9f543883f70d3
Notes Funding information
Authors would like to acknowledge Council of Scientific and Industrial Research (CSIR), Human Resource Development Group, Government of India for providing the research fellowship (08/602(0005)/19EMR‐I).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0001-8190-7031
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/sji.13124
PMID 34861056
PQID 2620434608
PQPubID 37516
PageCount 12
ParticipantIDs proquest_miscellaneous_2606925102
proquest_journals_2620434608
pubmed_primary_34861056
crossref_primary_10_1111_sji_13124
crossref_citationtrail_10_1111_sji_13124
wiley_primary_10_1111_sji_13124_SJI13124
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2022
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: February 2022
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Scandinavian journal of immunology
PublicationTitleAlternate Scand J Immunol
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 25
2007; 104
2010; 10
2017; 8
2012; 287
2011; 117
2019; 10
2010; 148
2002; 10
2019; 15
2019; 16
2006; 291
2010; 140
2014; 63
2013; 280
2012; 13
2012; 249
2007; 36
2014; 211
2012; 492
2015; 45
2018; 8
2007; 179
2010; 20
2001; 299
2014; 5
2013; 14
2018; 293
2021; 157
2006; 24
2013; 13
2010; 154
2005; 74
2016; 41
2009; 284
2017; 124
2018; 38
2013; 190
2016; 44
2014; 289
2009; 22
2009; 1787
2015; 160
2015; 6
2009; 21
2013; 49
2007; 282
2015; 95
2013; 45
2015; 97
2019; 78
2013; 85
2011; 30
1996
2010; 285
2011; 34
2015; 526
2020; 76
2004; 306
2016; 17
2017; 214
2016; 12
2018; 18
2018; 17
2013; 37
2004; 113
2011; 469
2017; 14
1997; 240
2020; 72
2020
2015; 66
2015; 21
2009; 187
2016; 530
2009; 9
2018
2007; 81
2005; 6
2016
2009; 183
2009; 7
2013; 493
2002; 71
2015
2009; 5
1998; 1
2013; 451
2008; 42
2003; 301
2016; 291
2012; 46
2011; 187
e_1_2_9_75_1
e_1_2_9_98_1
e_1_2_9_52_1
e_1_2_9_79_1
e_1_2_9_94_1
e_1_2_9_10_1
e_1_2_9_56_1
e_1_2_9_33_1
e_1_2_9_90_1
e_1_2_9_71_1
e_1_2_9_14_1
e_1_2_9_37_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_87_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_68_1
e_1_2_9_83_1
e_1_2_9_6_1
e_1_2_9_60_1
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_30_1
e_1_2_9_99_1
e_1_2_9_72_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_95_1
e_1_2_9_76_1
e_1_2_9_91_1
Chuang YT (e_1_2_9_53_1) 2011; 117
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_88_1
e_1_2_9_61_1
e_1_2_9_46_1
e_1_2_9_84_1
e_1_2_9_23_1
e_1_2_9_65_1
e_1_2_9_80_1
e_1_2_9_5_1
e_1_2_9_9_1
e_1_2_9_27_1
e_1_2_9_69_1
e_1_2_9_31_1
e_1_2_9_50_1
e_1_2_9_73_1
e_1_2_9_35_1
e_1_2_9_77_1
e_1_2_9_96_1
e_1_2_9_12_1
e_1_2_9_54_1
e_1_2_9_92_1
e_1_2_9_101_1
e_1_2_9_39_1
Perregaux DG (e_1_2_9_93_1) 2001; 299
e_1_2_9_16_1
e_1_2_9_58_1
Janeway CA (e_1_2_9_2_1) 1996
e_1_2_9_20_1
e_1_2_9_62_1
e_1_2_9_89_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_66_1
e_1_2_9_85_1
e_1_2_9_8_1
e_1_2_9_81_1
e_1_2_9_4_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_74_1
e_1_2_9_51_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_97_1
e_1_2_9_70_1
e_1_2_9_100_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_59_1
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_21_1
e_1_2_9_67_1
e_1_2_9_44_1
e_1_2_9_86_1
e_1_2_9_7_1
Jansen T (e_1_2_9_78_1) 2019; 78
e_1_2_9_82_1
e_1_2_9_3_1
e_1_2_9_25_1
e_1_2_9_48_1
e_1_2_9_29_1
References_xml – volume: 34
  start-page: 213
  year: 2011
  end-page: 223
  article-title: Type I interferon inhibits interleukin‐1 production and inflammasome activation
  publication-title: Immunity
– volume: 7
  start-page: 99
  year: 2009
  end-page: 109
  article-title: Pyroptosis: host cell death and inflammation
  publication-title: Nat Rev Microbiol
– volume: 66
  start-page: 1
  year: 2015
  end-page: 8
  article-title: Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and non‐ischemic injury in the mouse
  publication-title: J Cardiovasc Pharmacol
– volume: 24
  start-page: 353
  year: 2006
  end-page: 389
  article-title: Genetic analysis of host resistance: toll‐like receptor signaling and immunity at large
  publication-title: Annu Rev Immunol
– volume: 21
  start-page: 677
  year: 2015
  end-page: 687
  article-title: Inflammasomes: mechanism of action, role in disease, and therapeutics
  publication-title: Nat Med
– volume: 493
  start-page: 674
  year: 2013
  end-page: 678
  article-title: NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
  publication-title: Nature
– volume: 14
  start-page: 454
  issue: 5
  year: 2013
  end-page: 460
  article-title: Microtubule‐driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
  publication-title: Nat Immunol
– volume: 187
  start-page: 61
  year: 2009
  end-page: 70
  article-title: Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
  publication-title: J Cell Biol
– volume: 8
  year: 2018
  article-title: Function and biogenesis of lipopolysaccharides
  publication-title: EcoSal Plus
– volume: 451
  start-page: 427
  issue: 3
  year: 2013
  end-page: 437
  article-title: The anti‐inflammatory drug BAY 11–7082 suppresses the MyD88‐dependent signalling network by targeting the ubiquitin system
  publication-title: Biochemical J
– volume: 187
  start-page: 6143
  year: 2011
  end-page: 6156
  article-title: Inflammasome activation of IL‐18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus
  publication-title: J Immun
– volume: 78
  start-page: A70
  year: 2019
  end-page: A71
  article-title: P160 The first phase 2A proof‐of‐concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile™ (OLT1177™), in acute gout
  publication-title: Ann Rheum Dis
– volume: 5
  start-page: 316
  year: 2014
  article-title: A comparative review of toll‐like receptor 4 expression and functionality in different animal species
  publication-title: Front Immunol
– volume: 95
  start-page: 149
  year: 2015
  end-page: 178
  article-title: NOD‐like receptors: versatile cytosolic sentinels
  publication-title: Physiol Rev
– volume: 38
  start-page: 27
  issue: 1
  year: 2018
  article-title: Amyloid β directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell‐free system
  publication-title: Inflamm Regen
– volume: 21
  start-page: 263
  year: 2015
  end-page: 269
  article-title: The ketone metabolite β‐hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
  publication-title: Nat Med
– volume: 17
  start-page: 694
  year: 2018
  end-page: 702
  article-title: NLRP3: a promising therapeutic target for autoimmune diseases
  publication-title: Autoimmun Rev
– volume: 16
  start-page: 81
  year: 2019
  article-title: A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury
  publication-title: J Neuroinflammation
– volume: 154
  start-page: 551
  year: 2010
  end-page: 554
  article-title: Pathogen‐associated molecular pattern‐triggered immunity: veni, vidi…?
  publication-title: Plant Physiol
– volume: 97
  start-page: 825
  issue: 5
  year: 2015
  end-page: 835
  article-title: Syk is involved in NLRP3 inflammasome‐mediated caspase‐1 activation through adaptor ASC phosphorylation and enhanced oligomerization
  publication-title: J Leukoc Biol
– volume: 15
  start-page: 556
  issue: 6
  year: 2019
  end-page: 559
  article-title: MCC950 directly targets the NLRP3 ATP‐hydrolysis motif for inflammasome inhibition
  publication-title: Nat Chem Bio
– volume: 20
  start-page: 1289
  issue: 12
  year: 2010
  end-page: 1305
  article-title: Chemical probing reveals insights into the signaling mechanism of inflammasome activation
  publication-title: Cell Res
– volume: 160
  start-page: 62
  year: 2015
  end-page: 73
  article-title: Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
  publication-title: Cell
– volume: 63
  start-page: 316
  year: 2014
  end-page: 322
  article-title: A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury following ischemia‐reperfusion in the mouse
  publication-title: J Cardiovasc Pharmacol
– volume: 37
  start-page: 284
  year: 2013
  end-page: 291
  article-title: Pattern recognition receptors in innate immunity, host defense, and immunopathology
  publication-title: Adv Physiol Educ
– volume: 18
  start-page: e27
  year: 2018
  article-title: Damage‐associated molecular patterns in inflammatory diseases
  publication-title: Immune Netw
– volume: 284
  start-page: 24192
  year: 2009
  end-page: 24203
  article-title: MyD88 adapter‐like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2‐and TLR4‐mediated NF‐κB proinflammatory responses
  publication-title: J Biol Chem
– volume: 306
  start-page: 1186
  year: 2004
  end-page: 1188
  article-title: Microbial factor‐mediated development in a host‐bacterial mutualism
  publication-title: Science
– volume: 44
  start-page: 833
  issue: 4
  year: 2016
  end-page: 846
  article-title: Human monocytes engage an alternative inflammasome pathway
  publication-title: Immunity
– volume: 104
  start-page: 8041
  year: 2007
  end-page: 8046
  article-title: Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling
  publication-title: Proc Natl Acad Sci USA
– volume: 179
  start-page: 4083
  year: 2007
  end-page: 4092
  article-title: Role for MyD88‐independent, TRIF pathway in lipid A/TLR4‐induced endotoxin tolerance
  publication-title: J Immunol
– volume: 6
  start-page: 973
  year: 2005
  end-page: 979
  article-title: Are innate immune signaling pathways in plants and animals conserved?
  publication-title: Nat Immunol
– volume: 72
  start-page: 217
  year: 2020
  end-page: 224
  article-title: Differential expression of the inflammasome complex genes in systemic lupus erythematosus
  publication-title: Immunogenetics
– volume: 81
  start-page: 1
  year: 2007
  end-page: 5
  article-title: DAMPs, PAMPs and alarmins: all we need to know about danger
  publication-title: J Leukoc Biol
– volume: 85
  start-page: 1504
  year: 2013
  end-page: 1512
  article-title: A novel benzo [d] imidazole derivate prevents the development of dextran sulfate sodium‐induced murine experimental colitis via inhibition of NLRP3 inflammasome
  publication-title: Biochem Pharmacol
– volume: 249
  start-page: 158
  year: 2012
  end-page: 175
  article-title: PAMP s and DAMP s: signal 0s that spur autophagy and immunity
  publication-title: Immunol Rev
– volume: 301
  start-page: 640
  year: 2003
  end-page: 643
  article-title: Role of adaptor TRIF in the MyD88‐independent toll‐like receptor signaling pathway
  publication-title: Science
– volume: 13
  start-page: 255
  issue: 3
  year: 2012
  end-page: 263
  article-title: Activation of autophagy by inflammatory signals limits IL‐1β production by targeting ubiquitinated inflammasomes for destruction
  publication-title: Nat Immunol
– volume: 36
  start-page: 728
  year: 2007
  end-page: 736
  article-title: Parthenolide inhibits IκB kinase, NF‐κB activation, and inflammatory response in cystic fibrosis cells and mice
  publication-title: Am J Respir Cell Mol Biol
– volume: 6
  start-page: 262
  year: 2015
  article-title: NLRP3 inflammasome and its inhibitors: a review
  publication-title: Front Pharmacol
– volume: 526
  start-page: 660
  year: 2015
  end-page: 665
  article-title: Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
  publication-title: Nature
– volume: 117
  start-page: 960
  issue: 3
  year: 2011
  end-page: 970
  article-title: Tumor suppressor death‐associated protein kinase is required for full IL‐1β production
  publication-title: Am J Hematol
– start-page: 4
  year: 1996
  end-page: 5
– volume: 49
  start-page: 331
  year: 2013
  end-page: 338
  article-title: Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity
  publication-title: Mol Cell
– volume: 22
  start-page: 240
  year: 2009
  end-page: 273
  article-title: Pathogen recognition and inflammatory signaling in innate immune defenses
  publication-title: Clin Microbiol Rev
– volume: 71
  start-page: 635
  year: 2002
  end-page: 700
  article-title: Lipopolysaccharide endotoxins
  publication-title: Annu Rev Biochem
– start-page: 1055
  year: 2016
  end-page: 1069
– volume: 285
  start-page: 9792
  issue: 13
  year: 2010
  end-page: 9802
  article-title: Anti‐inflammatory compounds parthenolide and Bay 11–7082 are direct inhibitors of the inflammasome
  publication-title: J Biol Chem
– volume: 492
  start-page: 123
  issue: 7427
  year: 2012
  end-page: 127
  article-title: The calcium‐sensing receptor regulates the NLRP3 inflammasome through Ca 2+ and cAMP
  publication-title: Nature
– volume: 45
  start-page: e66
  year: 2013
  article-title: Recognition of lipopolysaccharide pattern by TLR4 complexes
  publication-title: Exp Mol Med
– volume: 240
  start-page: 419
  issue: 2
  year: 1997
  end-page: 424
  article-title: Nitric oxide reversibly inhibits seven members of the caspase family via S‐nitrosylation
  publication-title: Biochem Biophys Res Commun
– volume: 211
  start-page: 1333
  issue: 7
  year: 2014
  end-page: 1347
  article-title: The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation
  publication-title: J Exp Med
– volume: 13
  start-page: 453
  issue: 6
  year: 2013
  end-page: 460
  article-title: The history of toll‐like receptors — redefining innate immunity
  publication-title: Nat Rev Immunol
– volume: 8
  start-page: 36
  year: 2017
  article-title: Canonical and non‐canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation
  publication-title: Front Immunol
– volume: 12
  year: 2016
  article-title: Immune sensing of lipopolysaccharide in plants and animals: same but different
  publication-title: PLoS Pathog
– volume: 14
  start-page: 65
  issue: 1
  year: 2017
  end-page: 79
  article-title: Post‐translational regulation of inflammasomes
  publication-title: Cell Mol Immunol
– volume: 293
  start-page: 15195
  year: 2018
  end-page: 15207
  article-title: Interleukin‐1 receptor–associated kinase 4 (IRAK4) plays a dual role in myddosome formation and toll‐like receptor signaling
  publication-title: J Biol Chem
– volume: 113
  start-page: 153
  year: 2004
  end-page: 162
  article-title: Signal transduction by the lipopolysaccharide receptor, toll‐like receptor‐4
  publication-title: Immunology
– volume: 190
  start-page: 307
  year: 2013
  end-page: 316
  article-title: Complete dependence on IRAK4 kinase activity in TLR2, but Not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to streptococcus pneumoniae infection in IRAK4 kinase‐inactive mice
  publication-title: J Immun
– volume: 299
  start-page: 187
  year: 2001
  end-page: 197
  article-title: Identification and characterization of a novel class of interleukin‐1 post‐translational processing inhibitors
  publication-title: J Pharmacol Exp Ther
– volume: 17
  start-page: 250
  issue: 3
  year: 2016
  end-page: 258
  article-title: NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component
  publication-title: Nat Immunol
– volume: 74
  start-page: 355
  year: 2005
  end-page: 383
  article-title: NOD‐LRR proteins: role in host‐microbial interactions and inflammatory disease
  publication-title: Annu Rev Biochem
– year: 2015
– volume: 1787
  start-page: 1352
  issue: 11
  year: 2009
  end-page: 1362
  article-title: SR/ER–mitochondrial local communication: calcium and ROS
  publication-title: Biochim Biophys Acta Bioenerg
– volume: 8
  start-page: 1518
  year: 2017
  article-title: Isoliquiritigenin activates nuclear factor erythroid‐2 related factor 2 to suppress the NOD‐like receptor protein 3 inflammasome and inhibits the NF‐κB pathway in macrophages and in acute lung injury
  publication-title: Front Immunol
– volume: 287
  start-page: 41732
  year: 2012
  end-page: 41743
  article-title: Multiple binding sites on the pyrin domain of ASC protein allow self‐association and interaction with NLRP3 protein
  publication-title: J Biol Chem
– volume: 280
  start-page: 2830
  issue: 12
  year: 2013
  end-page: 2841
  article-title: The anti‐inflammatory compound BAY‐11‐7082 is a potent inhibitor of protein tyrosine phosphatases
  publication-title: FEBS J
– volume: 530
  start-page: 354
  issue: 7590
  year: 2016
  end-page: 357
  article-title: NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
  publication-title: Nature
– volume: 291
  start-page: C1082
  issue: 5
  year: 2006
  end-page: C1088
  article-title: Mitochondrial reactive oxygen species and Ca2+ signaling
  publication-title: Am J Physiol Cell Physiol
– volume: 21
  start-page: 248
  year: 2015
  end-page: 255
  article-title: A small‐molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
  publication-title: Nat Med
– volume: 5
  issue: 8
  year: 2009
  article-title: Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases
  publication-title: PLoS Pathog
– volume: 214
  start-page: 3219
  year: 2017
  end-page: 3238
  article-title: Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
  publication-title: J Exp Med
– volume: 76
  start-page: 100924
  year: 2020
  article-title: An overview of the non‐canonical inflammasome
  publication-title: Mol Aspects Med
– volume: 124
  start-page: 901
  year: 2017
  end-page: 905
  article-title: Epidemiology of Parkinson's disease
  publication-title: J Neural Transm
– start-page: 175
  year: 2018
  end-page: 187
– volume: 10
  start-page: 826
  year: 2010
  end-page: 837
  article-title: Sterile inflammation: sensing and reacting to damage
  publication-title: Nat Rev Immunol
– volume: 1
  start-page: 319
  year: 1998
  end-page: 325
  article-title: Autoproteolytic activation of pro‐caspases by oligomerization
  publication-title: Mol Cell
– volume: 25
  start-page: 5533
  issue: 23
  year: 2021
  article-title: Inhibiting the NLRP3 inflammasome
  publication-title: Molecules
– volume: 289
  start-page: 1142
  year: 2014
  end-page: 1150
  article-title: 3, 4‐methylenedioxy‐β‐nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome
  publication-title: J Biol Chem
– volume: 30
  start-page: 16
  year: 2011
  end-page: 34
  article-title: Pathogen recognition by the innate immune system
  publication-title: Int Rev Immunol
– volume: 183
  start-page: 787
  year: 2009
  end-page: 791
  article-title: Cutting edge: NF‐κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression
  publication-title: J Immun
– volume: 21
  start-page: 317
  year: 2009
  end-page: 337
  article-title: The roles of TLRs, RLRs and NLRs in pathogen recognition
  publication-title: Int Immunol
– volume: 10
  start-page: 417
  year: 2002
  end-page: 426
  article-title: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL‐β
  publication-title: Mol Cell
– volume: 285
  start-page: 9792
  year: 2010
  end-page: 9802
  article-title: Anti‐inflammatory compounds parthenolide and Bay 11–7082 are direct inhibitors of the inflammasome
  publication-title: J Biol Chem
– volume: 45
  start-page: 2918
  issue: 10
  year: 2015
  end-page: 2926
  article-title: NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase‐4 and caspase‐5
  publication-title: Eur J Immunol
– year: 2020
– volume: 291
  start-page: 103
  issue: 1
  year: 2016
  end-page: 109
  article-title: A genome‐wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation
  publication-title: J Biol Chem
– volume: 41
  start-page: 273
  year: 2016
  end-page: 279
  article-title: NF‐κB activation via MyD88‐dependent toll‐like receptor signaling is inhibited by trichothecene mycotoxin deoxynivalenol
  publication-title: J Toxicol Sci
– volume: 469
  start-page: 221
  issue: 7329
  year: 2011
  end-page: 225
  article-title: A role for mitochondria in NLRP3 inflammasome activation
  publication-title: Nature
– volume: 282
  start-page: 15319
  year: 2007
  end-page: 15323
  article-title: Toll‐like receptors and type I interferons
  publication-title: J Biol Chem
– volume: 140
  start-page: 821
  year: 2010
  end-page: 832
  article-title: The inflammasomes
  publication-title: Cell
– volume: 10
  start-page: 2538
  year: 2019
  article-title: Pharmacological inhibitors of the NLRP3 inflammasome
  publication-title: Front Immunol
– volume: 9
  start-page: 465
  year: 2009
  end-page: 479
  article-title: Signalling through C‐type lectin receptors: shaping immune responses
  publication-title: Nat Rev Immunol
– volume: 148
  start-page: 487
  issue: 3
  year: 2010
  end-page: 490
  article-title: IKK inhibitor bay 11–7082 induces necroptotic cell death in precursor‐B acute lymphoblastic leukaemic blasts
  publication-title: Br J Haematol
– volume: 157
  start-page: 105637
  year: 2021
  article-title: Inhibition of NLRP3‐inflammasome mediated IL‐1β release by phenylpropanoic acid derivatives: in‐silico and in‐vitro approach
  publication-title: Eur J Pharm Sci
– volume: 42
  start-page: 145
  year: 2008
  end-page: 151
  article-title: LPS/TLR4 signal transduction pathway
  publication-title: Cytokine
– volume: 46
  start-page: 815
  issue: 6
  year: 2012
  end-page: 822
  article-title: Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation
  publication-title: Am J Respir Cell Mol Biol
– ident: e_1_2_9_65_1
  doi: 10.1038/nature09663
– ident: e_1_2_9_73_1
  doi: 10.4049/jimmunol.1101284
– ident: e_1_2_9_5_1
  doi: 10.1111/j.1600-065X.2012.01146.x
– ident: e_1_2_9_46_1
  doi: 10.1038/cmi.2016.29
– ident: e_1_2_9_98_1
  doi: 10.1074/jbc.M113.515080
– ident: e_1_2_9_22_1
  doi: 10.1146/annurev.biochem.71.110601.135414
– ident: e_1_2_9_83_1
  doi: 10.1097/FJC.0000000000000053
– ident: e_1_2_9_24_1
  doi: 10.1038/nri3446
– ident: e_1_2_9_86_1
  doi: 10.1111/febs.12283
– ident: e_1_2_9_41_1
  doi: 10.1016/j.cell.2010.01.040
– ident: e_1_2_9_81_1
  doi: 10.3389/fimmu.2019.02538
– ident: e_1_2_9_95_1
  doi: 10.1186/s12974-019-1471-y
– ident: e_1_2_9_47_1
  doi: 10.1189/jlb.3HI0814-371RR
– ident: e_1_2_9_89_1
  doi: 10.1038/nm.3804
– ident: e_1_2_9_26_1
  doi: 10.1016/j.cyto.2008.01.006
– ident: e_1_2_9_25_1
  doi: 10.3389/fimmu.2014.00316
– ident: e_1_2_9_61_1
  doi: 10.1016/j.immuni.2016.01.012
– ident: e_1_2_9_82_1
  doi: 10.3390/molecules25235533
– ident: e_1_2_9_62_1
  doi: 10.1038/nature11588
– ident: e_1_2_9_67_1
  doi: 10.1002/eji.201545655
– ident: e_1_2_9_27_1
  doi: 10.1111/j.1365-2567.2004.01976.x
– ident: e_1_2_9_19_1
  doi: 10.4110/in.2018.18.e27
– ident: e_1_2_9_79_1
– ident: e_1_2_9_16_1
  doi: 10.1152/advan.00058.2013
– ident: e_1_2_9_11_1
  doi: 10.1038/nri2569
– ident: e_1_2_9_14_1
  doi: 10.1146/annurev.biochem.74.082803.133347
– ident: e_1_2_9_6_1
  doi: 10.1038/ni1253
– ident: e_1_2_9_70_1
  doi: 10.1038/nature11729
– ident: e_1_2_9_91_1
  doi: 10.1016/j.bcp.2013.03.008
– ident: e_1_2_9_48_1
  doi: 10.1371/journal.ppat.1000559
– ident: e_1_2_9_18_1
  doi: 10.1104/pp.110.161547
– ident: e_1_2_9_64_1
  doi: 10.1016/j.bbabio.2009.06.004
– ident: e_1_2_9_97_1
  doi: 10.1038/nm.3806
– ident: e_1_2_9_99_1
  doi: 10.1074/jbc.M109.082305
– volume: 117
  start-page: 960
  issue: 3
  year: 2011
  ident: e_1_2_9_53_1
  article-title: Tumor suppressor death‐associated protein kinase is required for full IL‐1β production
  publication-title: Am J Hematol
– ident: e_1_2_9_10_1
  doi: 10.1146/annurev.immunol.24.021605.090552
– ident: e_1_2_9_88_1
  doi: 10.1042/BJ20121651
– ident: e_1_2_9_38_1
  doi: 10.1038/nm.3893
– ident: e_1_2_9_36_1
  doi: 10.1152/physrev.00009.2014
– ident: e_1_2_9_75_1
  doi: 10.1007/s00251-020-01158-6
– ident: e_1_2_9_31_1
  doi: 10.1074/jbc.RA118.003314
– ident: e_1_2_9_49_1
  doi: 10.1038/ni.3333
– ident: e_1_2_9_87_1
  doi: 10.1111/j.1365-2141.2009.07988.x
– ident: e_1_2_9_7_1
  doi: 10.1126/science.1102218
– ident: e_1_2_9_54_1
  doi: 10.1038/ni.2215
– ident: e_1_2_9_9_1
  doi: 10.1038/nri2873
– ident: e_1_2_9_45_1
  doi: 10.4049/jimmunol.0901363
– ident: e_1_2_9_43_1
  doi: 10.1016/j.molcel.2012.11.009
– ident: e_1_2_9_101_1
  doi: 10.1016/j.ejps.2020.105637
– ident: e_1_2_9_30_1
  doi: 10.1084/jem.21213insight1
– ident: e_1_2_9_92_1
  doi: 10.1083/jcb.200903124
– ident: e_1_2_9_58_1
  doi: 10.1016/S1097-2765(00)80032-5
– ident: e_1_2_9_35_1
  doi: 10.1074/jbc.R700009200
– volume: 78
  start-page: A70
  year: 2019
  ident: e_1_2_9_78_1
  article-title: P160 The first phase 2A proof‐of‐concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile™ (OLT1177™), in acute gout
  publication-title: Ann Rheum Dis
– ident: e_1_2_9_12_1
  doi: 10.1093/intimm/dxp017
– ident: e_1_2_9_69_1
  doi: 10.1186/s41232-018-0085-6
– ident: e_1_2_9_42_1
  doi: 10.1016/j.immuni.2011.02.006
– start-page: 4
  volume-title: Immunobiology: The Immune System in Health and Disease
  year: 1996
  ident: e_1_2_9_2_1
– ident: e_1_2_9_51_1
  doi: 10.1038/nature16959
– ident: e_1_2_9_71_1
  doi: 10.1007/s00702-017-1686-y
– ident: e_1_2_9_74_1
  doi: 10.1016/j.autrev.2018.01.020
– ident: e_1_2_9_50_1
  doi: 10.1074/jbc.C115.700492
– volume: 299
  start-page: 187
  year: 2001
  ident: e_1_2_9_93_1
  article-title: Identification and characterization of a novel class of interleukin‐1 post‐translational processing inhibitors
  publication-title: J Pharmacol Exp Ther
– ident: e_1_2_9_13_1
  doi: 10.1128/CMR.00046-08
– ident: e_1_2_9_44_1
  doi: 10.1074/jbc.M112.381228
– ident: e_1_2_9_15_1
  doi: 10.3109/08830185.2010.529976
– ident: e_1_2_9_21_1
  doi: 10.1128/ecosalplus.ESP-0001-2018
– ident: e_1_2_9_100_1
  doi: 10.1165/rcmb.2006-0323OC
– ident: e_1_2_9_96_1
  doi: 10.1038/s41589-019-0277-7
– ident: e_1_2_9_39_1
  doi: 10.3389/fimmu.2017.00036
– ident: e_1_2_9_40_1
  doi: 10.1016/S1097-2765(02)00599-3
– ident: e_1_2_9_28_1
  doi: 10.4049/jimmunol.179.6.4083
– ident: e_1_2_9_68_1
  doi: 10.1016/j.mam.2020.100924
– ident: e_1_2_9_34_1
  doi: 10.1074/jbc.M109.023044
– ident: e_1_2_9_55_1
  doi: 10.1084/jem.20132486
– ident: e_1_2_9_76_1
– ident: e_1_2_9_3_1
  doi: 10.3389/fphar.2015.00262
– ident: e_1_2_9_4_1
  doi: 10.1189/jlb.0306164
– ident: e_1_2_9_29_1
  doi: 10.1126/science.1087262
– ident: e_1_2_9_8_1
  doi: 10.1007/978-3-7643-8550-7_35
– ident: e_1_2_9_60_1
  doi: 10.1038/nrmicro2070
– ident: e_1_2_9_20_1
  doi: 10.1371/journal.ppat.1005596
– ident: e_1_2_9_17_1
  doi: 10.1016/B978-0-12-805417-8.00014-7
– ident: e_1_2_9_77_1
– ident: e_1_2_9_84_1
  doi: 10.1097/FJC.0000000000000247
– ident: e_1_2_9_59_1
  doi: 10.1038/nature15514
– ident: e_1_2_9_52_1
  doi: 10.1038/cr.2010.135
– ident: e_1_2_9_37_1
  doi: 10.1073/pnas.0611496104
– ident: e_1_2_9_66_1
  doi: 10.1038/ni.2550
– ident: e_1_2_9_57_1
  doi: 10.1165/rcmb.2011-0135OC
– ident: e_1_2_9_56_1
  doi: 10.1006/bbrc.1997.7672
– ident: e_1_2_9_32_1
  doi: 10.4049/jimmunol.1201644
– ident: e_1_2_9_94_1
  doi: 10.3389/fimmu.2017.01518
– ident: e_1_2_9_23_1
  doi: 10.1038/emm.2013.97
– ident: e_1_2_9_33_1
  doi: 10.2131/jts.41.273
– ident: e_1_2_9_63_1
  doi: 10.1152/ajpcell.00217.2006
– ident: e_1_2_9_85_1
  doi: 10.1074/jbc.M109.082305
– ident: e_1_2_9_72_1
  doi: 10.1016/j.cell.2014.11.047
– ident: e_1_2_9_80_1
– ident: e_1_2_9_90_1
  doi: 10.1084/jem.20171419
SSID ssj0013273
Score 2.4933043
SecondaryResourceType review_article
Snippet Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e13124
SubjectTerms Alarmins - metabolism
Caspase
Caspase 1 - immunology
Cell death
Cell Membrane - metabolism
Cell membranes
Enzyme Inhibitors - pharmacology
Humans
Immunity, Innate - immunology
inflammasome inhibitors
Inflammasomes
Inflammation
Innate immunity
Interleukin-18 - metabolism
Interleukin-1beta - metabolism
Intracellular Signaling Peptides and Proteins - immunology
Intracellular signalling
NLR Family, Pyrin Domain-Containing 3 Protein - antagonists & inhibitors
NLR Family, Pyrin Domain-Containing 3 Protein - metabolism
NLRP3 inflammasome
Pathogen-Associated Molecular Pattern Molecules - metabolism
Phosphate-Binding Proteins - immunology
Proteolysis
Pyroptosis
Pyroptosis - immunology
Signal transduction
Signal Transduction - immunology
Toll-Like Receptors - metabolism
Title Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fsji.13124
https://www.ncbi.nlm.nih.gov/pubmed/34861056
https://www.proquest.com/docview/2620434608
https://www.proquest.com/docview/2606925102
Volume 95
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRSAuPAqUhVIZxIFLVk5s5yFOLbAqVVuhpZV6QIrs2BYBkqyaXcFy4ifwG_kljJ1kteUhIU6JlHHseGbsz5kXwNOYJ5bqSASFNAUeUDIWpDHXAbPIYyWVCBMXO3x8Eh-c8cNzcb4Bz4dYmC4_xOqHm9MMv147BZeqXVPy9kM5DhluT7j-Ol8tB4im0ZoFobMuM0qDjCeizyrkvHhWLS_vRb8BzMt41W84k5vwbhhq52fycbyYq3Hx9Zcsjv_5LbfgRg9EyV4nObdhw9RbcLUrTbncgmvHvdH9Dnzp7Ae4xxFEi6SsPGRHYSGNJadH0x_fvp8cTd8wvM6WF81s3rRlS1yp489ySWStSWVcfHHZVq7Fek0B4hsSlHIUzEq2TYXvr9-XqnRFgO7C2eTV6YuDoC_YEBRccB4kKbcyCqXgUsUqYVKEBuFBZjlTVPNIJ1ZLhJRFQRPEpZRaZTIrOEtTZhOq2T3YrJva3AeSGisk16lOWIaIT0mqQ2syzoyLGwzpCJ4NrMuLPpu5K6rxKR9ONTinuZ_TETxZkc66FB5_ItoZ-J_3WtzmPlk_4zFNR_B49Rj1zxlVZG2ahaOhcYYgkUYj2O7kZtUL4ymiUxHjYD33_959_vbwtb958O-kD-F65GIxvAv5DmzOLxbmESKkudqFK3v7L_cnu14lfgJSlA9Q
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4ti3hceCwLFBYwiAOXVE5s5yFxQYhVd2krVLrSXlBkJ7YI0KTatIJy4ifwG_kljJ2HujwkxCmRMo4deybzjcczA_A05JGheSC8TOoMDZSEeXHIc48ZXGMllfAjGzs8mYajE358Kk534HkXC9Pkh-g33KxkuP-1FXC7Ib0l5fWHYugz1E8X4KKt6O0Mqlmw5UNo_MuMUi_hkWjzCtlzPH3T89roN4h5HrE6lXN4Hd51g21OmnwcrldqmH39JY_j_37NDbjWYlHyomGem7Cjyz241FSn3OzB5Unrd78FXxoXAqo5goCRFAuH2pFfSGXIfDz78e37dDx7w_C63JxVy1VVFzWx1Y4_yw2RZU4W2oYYF_XCttguK0BcQ4KMjry5kHW1wPeX7wtV2DpA-3By-Gr-cuS1NRu8jAvOvSjmRga-FFyqUEVMCl8jQkgMZ4rmPMgjk0tElVlGI4SmlBqlEyM4i2NmIpqz27BbVqW-CyTWRkiex3nEEgR9StLcNzrhTNvQQZ8O4Fm3dmnWJjS3dTU-pZ1hg3OaujkdwJOedNlk8fgT0UHHAGkryHXq8vUzHtJ4AI_7xyiC1q8iS12tLQ0NE8SJNBjAnYZx-l4YjxGgihAH65b_792nb4-P3M29fyd9BFdG88k4HR9NX9-Hq4ENzXAnyg9gd3W21g8QMK3UQycXPwGkeRH5
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIiouPMproYBBHLhk5cTOS5wQZdWW7apaWqkHpMiObZGWJKtmV7Cc-An8Rn4JYycbbXlIiFMiZRw7npnMZ49nBuBFxGNDVRB6udA5LlBS5iURVx4zyGMpZOjHNnb4cBLtnfCD0_B0A16tYmHa_BD9hpvVDPe_tgo-U2ZNyZuzYugzNE9X4CqPaGJFencarLkQWvcyo9RLeRx2aYXsMZ6-6WVj9BvCvAxYncUZ3YQPq7G2B03Oh4u5HOZff0nj-J8fcwtudEiUvG5F5zZs6GobrrW1KZfbsHXYed3vwJfWgYBGjiBcJEXpMDtKC6kNOR5Pf3z7PhlPjxheZ8uLejavm6IhttbxZ7EkolKk1DbAuGhK22K9qABxDQmKOUpmKZq6xPdXHwtZ2CpAd-Fk9Pb4zZ7XVWzwch5y7sUJNyLwRciFjGTMROhrxAep4UxSxQMVGyUQU-Y5jRGYUmqkTk3IWZIwE1PF7sFmVVf6AZBEm1BwlaiYpQj5pKDKNzrlTNvAQZ8O4OWKdVnepTO3VTU-ZatlDc5p5uZ0AM970lmbw-NPRDsr_medGjeZy9bPrHQN4Fn_GBXQelVEpeuFpaFRiiiRBgO438pN3wvjCcLTMMLBOu7_vfvs_cG-u3n476RPYetod5SN9yfvHsH1wMZluOPkO7A5v1jox4iW5vKJ04qfhV4QsQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reviewing+the+importance+of+TLR-NLRP3-pyroptosis+pathway+and+mechanism+of+experimental+NLRP3+inflammasome+inhibitors&rft.jtitle=Scandinavian+journal+of+immunology&rft.au=Kinra%2C+Manas&rft.au=Nampoothiri%2C+Madhavan&rft.au=Arora%2C+Devinder&rft.au=Mudgal%2C+Jayesh&rft.date=2022-02-01&rft.eissn=1365-3083&rft.volume=95&rft.issue=2&rft.spage=e13124&rft_id=info:doi/10.1111%2Fsji.13124&rft_id=info%3Apmid%2F34861056&rft.externalDocID=34861056
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-9475&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-9475&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-9475&client=summon